Literature DB >> 17490999

Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.

David Landman1, Simona Bratu, Sandeep Kochar, Monica Panwar, Manoj Trehan, Mehmet Doymaz, John Quale.   

Abstract

OBJECTIVES: To document resistance patterns of three important nosocomial pathogens, Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, present in hospitals in Brooklyn, NY.
METHODS: Susceptibility profiles of pathogens gathered during a surveillance study in 2006 were analysed and compared with similar surveys performed in 1999 and 2001. MICs were determined according to CLSI standards, and selected isolates were screened by PCR for the presence of VIM, IMP and KPC beta-lactamases.
RESULTS: For P. aeruginosa, susceptibility to most antimicrobials fell in 2001 and then reached a plateau. However, there was a progressive decrease in the number of patients with P. aeruginosa during the three surveys. While the total number of isolates of A. baumannii remained steady, there was a progressive decrease in susceptibility to most classes of antimicrobial agents, and approximately one-third had combined resistance to carbapenems, fluoroquinolones and aminoglycosides. There was a noticeable rise in the number of isolates of K. pneumoniae over the surveillance periods, suggesting that this has become the predominant pathogen in many medical centres. Over one-third of K. pneumoniae collected in 2006 carried the carbapenemase KPC, and 22% were resistant to all three classes of antimicrobial agents.
CONCLUSIONS: Hospitals in our region have been beset with antimicrobial-resistant Gram-negative bacteria. K. pneumoniae has rapidly emerged as the most common multidrug-resistant pathogen. Improved therapeutic agents and methods of detection are needed to reduce transmission of these bacteria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490999     DOI: 10.1093/jac/dkm129

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  52 in total

1.  Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Authors:  David Landman; Carl Urban; Martin Bäcker; Paul Kelly; Neha Shah; Elizabeth Babu; Simona Bratu; John Quale
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

2.  Porin Loss Impacts the Host Inflammatory Response to Outer Membrane Vesicles of Klebsiella pneumoniae.

Authors:  Kelli L Turner; Bethaney K Cahill; Sarah K Dilello; Dedra Gutel; Debra N Brunson; Sebastián Albertí; Terri N Ellis
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

3.  In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase.

Authors:  Dora E Wiskirchen; Pornpan Koomanachai; Anthony M Nicasio; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

Review 4.  Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors:  Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

5.  Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.

Authors:  Jonas Marschall; Robert J Tibbetts; W Michael Dunne; Jonathan G Frye; Victoria J Fraser; David K Warren
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

Review 6.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.

Authors:  Anna Baraniak; Radosław Izdebski; Małgorzata Herda; Janusz Fiett; Waleria Hryniewicz; Marek Gniadkowski; Izabela Kern-Zdanowicz; Krzysztof Filczak; Urszula Łopaciuk
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints.

Authors:  David Landman; Julius Salamera; Manisha Singh; John Quale
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

Review 9.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic.

Authors:  Daniel J Morgan; Scott A Weisenberg; Michael H Augenbraun; David P Calfee; Brian P Currie; E Yoko Furuya; Robert Holzman; Marisa C Montecalvo; Michael Phillips; Bruce Polsky; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2009-02       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.